Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)

Market Overview:

The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections.

Market Dynamics:

Growing Prevalence of Cataracts: Cataracts, which are the primary cause of blindness worldwide, are increasingly prevalent, particularly among the elderly population. As cataracts affect more individuals, the adoption of intravitreal injectables, including antibiotics and steroids, as part of routine cataract surgery is on the rise.

Risks Associated with Intravitreal Injections: Intravitreal injections carry various risks, including pain, infection, bleeding, retinal tears or detachment, cataract formation, visual impairment, and even eye loss in severe cases. These risks may deter patients from seeking treatment and consequently hamper market growth.

For More Insight: https://www.datamintelligence.com/download-sample/intravitreal-injectable-market

Segmentation Analysis:

Anti-VEGF Segment Dominates: The anti-VEGF segment held the largest market share in 2021. Anti-VEGF drugs, such as ranibizumab, have demonstrated safety and efficacy in reducing fluid leakage in eye disorders like wet age-related macular degeneration. These drugs target chronic retinal diseases, contributing to their widespread use among ophthalmologists.

Geographical Share:

North America Leads the Market: North America accounted for the largest market share in 2021, driven by factors such as the increasing prevalence of eye disorders, a growing geriatric population, and rising FDA approvals for intravitreal injectables. For instance, the prevalence of age-related macular degeneration in the U.S. underscores the demand for effective treatments like intravitreal injections.

To access the complete report: https://www.datamintelligence.com/research-report/intravitreal-injectable-market

Major Companies:

Key Players: Major players in the intravitreal injectable market include Alcon Pharmaceuticals, Valeant Pharmaceuticals International, Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Novartis AG, Allergan, Alimera Sciences, ThromboGenics, Inc., Bristol-Myers Squibb Company, and Bausch & Lomb. These companies drive market growth through drug development and innovation to address retinal diseases effectively. For instance, Roche's FDA approval for Susvimo for the treatment of wet age-related macular degeneration demonstrates ongoing efforts to meet patient needs.

Related Reports:

Automated Compounding Devices Market: https://www.datamintelligence.com/research-report/automated-compounding-devices-market

Vernal Keratoconjunctivitis Drugs Market: https://www.datamintelligence.com/research-report/vernal-keratoconjunctivitis-drugs-market

Mastocytosis Treatment Market: https://www.datamintelligence.com/research-report/mastocytosis-treatment-market

Congenital Hyperinsulinism Treatment Market: https://www.datamintelligence.com/research-report/congenital-hyperinsulinism-treatment-market

Chronic Lower Back Pain Drugs Market: https://www.datamintelligence.com/research-report/chronic-lower-back-pain-drugs-market

Diffuse Cutaneous Systemic Sclerosis (DcSSc) Drugs Market: https://www.datamintelligence.com/research-report/diffuse-cutaneous-systemic-sclerosis-drugs-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: DataMIntelligence

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.